Recently, ultrasonography has provided a safe and efficient means of guidance for biopsy of native kidneys [2] [3] [4] [5] [6] . Because of prior difficulties with both open and blind percutaneous allograft biopsy methods, we have performed transplant biopsies with the aid of ultrasonographic localization since 1976. We report here the procedure used and the results of the last 50 biopsies performed with this technique.
Renal allograft biopsies were performed (1) to confirm the diagnosis or assess the response to treatment of acute rejection episodes with atypical" presentations; (2) to diagnose the etiology of unexplained heavy proteinuria; (3) to confirm the absence of rejection in patients with prolonged allograft dysfunction attributed to acute tubular necrosis; (4) to distinguish chronic rejection from superimposed reversible causes of acute renal deterioration.
Methods
Prior to the biopsy, routine coagulation studies are obtained, and blood pressure is controlled to less than 100 mm Hg diastolic. Ultrasound of the lower abdomen and pelvic region is then performed with either a contact or water-delay scanner and a real-time scanner. Images in parasagittal, transverse, and oblique planes fully define the allograft and adjacent tissues. Evaluation for hydronephrosis, perirenal collections of fluid, and renal size is carried out. Aspiration of perirenal fluid collections may be performed with repeat ultrasonography to ensure adequacy of fluid removal.
The most accessible pole of the kidney is then carefully localized. The required angulation of the 471 biopsy needle is determined by observing the angulation of the ultrasound transducer. The depth of needle penetration is measured from the scale superimposed on the ultrasound image. It has not been necessary to use either a center-hole or notched transducer for needle guidance. Photographs of the images are made and retained as part of the permanent record (Fig. 1, A and B) .
The patient's abdomen is then prepared, and a renal biopsy is performed in the routine manner. The needle may be inserted perpendicular to the kidney capsule over one pole of the kidney, or obliquely at the discretion of the operator. Because the kidney lies superficially, in recent transplants only mild pressure is needed to reach the cortex. In some transplants of long duration, a thick fibrous pseudocapsule may form, requiring firm but restrained pressure to allow the biopsy needle to just enter the cortex of the graft. Some operators prefer to limit the advance of the needle sheath with a clamp placed on the trochar at the depth of the kidney as indicated by ultrasound.
The patient is monitored following the biopsy in the routine fashion. Repeat ultrasonography may be performed if complications are suspected.
Results
With the use of ultrasound guidance, we have performed more than 75 transplant biopsies since 1975. Detailed results of tissue obtained and the clinical course of the patients were analyzed on the last 50 consecutive biopsies since 1976. Twentythree patients had one biopsy of a renal allograft, six had two biopsies, two had three biopsies, and uli or renal medullary tissue alone. Although at times helpful, this was often inadequate for a complete diagnosis and a repeat biopsy was commonly performed under ultrasound. Two biopsies did not obtain renal tissue: both obtained skeletal muscle and adipose tissue. It must be stressed that a number of the biopsies performed, including the two that did not obtain renal tissue, were performed in a teaching setting. Success rates using only experienced operators might be expected to be even higher.
Mean decrease in hematocrit following biopsy was less than 1%, and median decrease was 1.5%. Although microscopic hematuria was common and self-limited, gross hematuria was rarely observed. Only one significant complication occurred in a patient whose blood pressure was not adequately controlled prior to biopsy (100 to 105 mm Hg diastolic).
This patient developed gross hematuria requiring transfusion of 2 U of blood. She had no deterioration of her renal function and has subsequently been followed for 2.5 years with stable renal function.
Blood pressure is now routinely controlled to levels of less than 100 mm Hg diastolic prior to percutaneous renal biopsy.
Discussion
Renal allograft biopsy frequently provides information useful in the management of transplant recipients [1] . The safety and efficacy of the technique of biopsy is critical to its use in this fragile population with a solitary functioning renal transplant.
In the past, several methods have been used to localize the appropriate site for allograft biopsy.
Operative ("open") surgical biopsy, although ensuring an adequate tissue specimen, requires an operative incision with the attendant risks of poor wound healing and infection in the immuno suppressed population [7] . The procedure is done in the operating room, may be difficult to perform under local anesthesia, and the number of repeat biopsies is limited. Percutaneous allograft biopsy at the bedside ("blind") relies on the ability of the operator to manually palpate the transplanted organ [8, 9] . In those patients with abnormally situated transplants, or grafts of long duration encased in fibrous tissue, and in those obese patients with grafts buried in abdominal fat, this technique may fail to localize the kidney. Even when the kidney is palpable, it may be so rotated that the needle is inadvertently directed towards the hilum, the ureter, or large blood vessels. Biopsy with the use of i.v. contrast agents and fluoroscopy may provide excellent localization of the renal cortex. It often, however, will not visualize the kidney suffering from acute tubular necrosis or severe rejection, and exposes the allograft to be biopsied to the risk of contrast nephropathy [10, 11] . Because the allograft to be biopsied often has prior dysfunction, this risk is a significant one. Recently, the placement of silver clips to outline the allograft's outer margin has been advocated for biopsy guidance [12] . Unfortunately, clips may migrate with time, and the allograft's position in relation to the clip may change. Moreover, the depth from the skin to the cortex is not indicated by this technique.
Renal ultrasound has been successfully used to localize the lower pole of the native kidneys for biopsy [2] [3] [4] [5] [6] . It has also been used extensively in the renal allograft to measure the size of the transplanted kidney [13] , as an aid to diagnosis of rejection [14, 15] , to delineate perirenal fluid collection [16] [17] [18] , and to exclude hydronephrosis as a cause of graft dysfunction [19] . Unfortunately, there is scanty documentation of the value of ultrasound as a guide to the biopsy of transplanted kidneys [18, [20] [21] [22] .
The use of ultrasound to localize a site for biopsy of a renal allograft has specific distinct advantages.
The perinephric area is examined at the time of biopsy to exclude abnormal fluid collections, which might interfere with a biopsy. Hydronephrosis of the transplant can be excluded. The procedure may be done even if the kidney cannot be palpated; it does not depend on the presence of clips, which may migrate; the hilum of the kidney is readily defined, and either pole of the kidney can be biopsied without fear of entering the peritoneal cavity. The exact depth from the skin to the kidney can be easily determined. The procedure requires no potentially nephrotoxic contrast agents, and there is no radiation exposure to the patient or operator. A biopsy site can be localized even in patients with severe renal dysfunction, and the problems associated with operative ("open") renal biopsy are avoided.
This series of 50 transplant biopsies demonstrates the use of ultrasound to localize an allograft biopsy site to be a safe and efficient procedure. This procedure, however, is still not without risk, and strict attention to routine prebiopsy coagulation studies and blood pressure control is mandatory. Obtaining adequate tissue for diagnosis depends on the experience of the operator and the ultrasonographer. Nevertheless, the use of renal ultrasound makes allograft biopsy a simple and relatively safe procedure.
